1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	Antibiotics	_	_	NNS	_	_	_	_	_
2	are	_	_	VBP	_	_	_	_	_
3	medicines	_	_	NNS	_	_	_	_	_
4	that	_	_	WDT	_	_	_	_	_
5	fight	_	_	VBP	_	_	_	_	_
6	bacterial	_	_	JJ	_	_	_	_	_
7	infections	_	_	NNS	_	_	_	_	_
8	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	can	_	_	MD	_	_	_	_	_
3	save	_	_	VB	_	_	_	_	_
4	lives	_	_	NNS	_	_	_	_	_
5	if	_	_	IN	_	_	_	_	_
6	they	_	_	PRP	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	used	_	_	VBN	_	_	_	_	_
9	correctly	_	_	RB	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	but	_	_	CC	_	_	_	_	_
12	nowadays	_	_	RB	_	_	_	_	_
13	antibiotic	_	_	JJ	_	_	_	_	_
14	resistance	_	_	NN	_	_	_	_	_
15	has	_	_	VBZ	_	_	_	_	_
16	become	_	_	VBN	_	_	_	_	_
17	a	_	_	DT	_	_	_	_	_
18	real	_	_	JJ	_	_	_	_	_
19	problem	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Infections	_	_	NNS	_	_	_	_	_
2	by	_	_	IN	_	_	_	_	_
3	resistant	_	_	JJ	_	_	_	_	_
4	microorganisms	_	_	NNS	_	_	_	_	_
5	do	_	_	VBP	_	_	_	_	_
6	not	_	_	RB	_	_	_	_	_
7	respond	_	_	VB	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	treatment	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	so	_	_	RB	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	duration	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	disease	_	_	NN	_	_	_	_	_
17	is	_	_	VBZ	_	_	_	_	_
18	prolonged	_	_	VBN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	risk	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	death	_	_	NN	_	_	_	_	_
25	increases	_	_	VBZ	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Moreover	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	if	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	treatment	_	_	NN	_	_	_	_	_
6	fails	_	_	VBZ	_	_	_	_	_
7	or	_	_	CC	_	_	_	_	_
8	if	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	response	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	treatment	_	_	NN	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	slow	_	_	JJ	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	patient	_	_	NN	_	_	_	_	_
18	is	_	_	VBZ	_	_	_	_	_
19	contagious	_	_	JJ	_	_	_	_	_
20	for	_	_	IN	_	_	_	_	_
21	longer	_	_	RBR	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	which	_	_	WDT	_	_	_	_	_
24	increases	_	_	VBZ	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	likelihood	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	resistant	_	_	JJ	_	_	_	_	_
29	microorganisms	_	_	NNS	_	_	_	_	_
30	being	_	_	VBG	_	_	_	_	_
31	transmitted	_	_	VBN	_	_	_	_	_
32	to	_	_	TO	_	_	_	_	_
33	other	_	_	JJ	_	_	_	_	_
34	people	_	_	NNS	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	emergence	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	antibiotic	_	_	JJ	_	_	_	_	_
5	resistance	_	_	NN	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	natural	_	_	JJ	_	_	_	_	_
9	biological	_	_	JJ	_	_	_	_	_
10	phenomenon	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	even	_	_	RB	_	_	_	_	_
14	though	_	_	IN	_	_	_	_	_
15	numerous	_	_	JJ	_	_	_	_	_
16	factors	_	_	NNS	_	_	_	_	_
17	have	_	_	VBP	_	_	_	_	_
18	been	_	_	VBN	_	_	_	_	_
19	identified	_	_	VBN	_	_	_	_	_
20	as	_	_	IN	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	cause	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	this	_	_	DT	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	such	_	_	JJ	_	_	_	_	_
27	as	_	_	IN	_	_	_	_	_
28	clustering	_	_	VBG	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	overcrowding	_	_	NN	_	_	_	_	_
31	or	_	_	CC	_	_	_	_	_
32	increased	_	_	VBN	_	_	_	_	_
33	elderly	_	_	JJ	_	_	_	_	_
34	population	_	_	NN	_	_	_	_	_
35	,	_	_	,	_	_	_	_	_
36	one	_	_	CD	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	the	_	_	DT	_	_	_	_	_
39	most	_	_	RBS	_	_	_	_	_
40	important	_	_	JJ	_	_	_	_	_
41	factors	_	_	NNS	_	_	_	_	_
42	is	_	_	VBZ	_	_	_	_	_
43	the	_	_	DT	_	_	_	_	_
44	inadequate	_	_	JJ	_	_	_	_	_
45	use	_	_	NN	_	_	_	_	_
46	of	_	_	IN	_	_	_	_	_
47	antibiotics	_	_	NNS	_	_	_	_	_
48	,	_	_	,	_	_	_	_	_
49	a	_	_	DT	_	_	_	_	_
50	very	_	_	RB	_	_	_	_	_
51	worrying	_	_	JJ	_	_	_	_	_
52	situation	_	_	NN	_	_	_	_	_
53	especially	_	_	RB	_	_	_	_	_
54	for	_	_	IN	_	_	_	_	_
55	healthcare	_	_	NN	_	_	_	_	_
56	professionals	_	_	NNS	_	_	_	_	_
57	with	_	_	IN	_	_	_	_	_
58	high	_	_	JJ	_	_	_	_	_
59	rate	_	_	NN	_	_	_	_	_
60	of	_	_	IN	_	_	_	_	_
61	antibiotic	_	_	JJ	_	_	_	_	_
62	prescription	_	_	NN	_	_	_	_	_
63	such	_	_	JJ	_	_	_	_	_
64	as	_	_	IN	_	_	_	_	_
65	primary	_	_	JJ	_	_	_	_	_
66	care	_	_	NN	_	_	_	_	_
67	dentists	_	_	NNS	_	_	_	_	_
68	.	_	_	.	_	_	_	_	_


1	According	_	_	VBG	_	_	_	_	_
2	to	_	_	TO	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	World	_	_	NNP	_	_	_	_	_
5	Health	_	_	NNP	_	_	_	_	_
6	Organization	_	_	NNP	_	_	_	_	_
7	(	_	_	-LRB-	_	_	_	_	_
8	WHO	_	_	NNP	_	_	_	_	_
9	)	_	_	-RRB-	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	inadequate	_	_	JJ	_	_	_	_	_
12	use	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	antibiotics	_	_	NNS	_	_	_	_	_
15	includes	_	_	VBZ	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	prescription	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	inappropriate	_	_	JJ	_	_	_	_	_
20	antibiotics	_	_	NNS	_	_	_	_	_
21	for	_	_	IN	_	_	_	_	_
22	a	_	_	DT	_	_	_	_	_
23	brief	_	_	JJ	_	_	_	_	_
24	time	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	low	_	_	JJ	_	_	_	_	_
28	or	_	_	CC	_	_	_	_	_
29	insufficient	_	_	JJ	_	_	_	_	_
30	doses	_	_	NNS	_	_	_	_	_
31	and/or	_	_	NN	_	_	_	_	_
32	for	_	_	IN	_	_	_	_	_
33	diseases	_	_	NNS	_	_	_	_	_
34	for	_	_	IN	_	_	_	_	_
35	which	_	_	WDT	_	_	_	_	_
36	they	_	_	PRP	_	_	_	_	_
37	are	_	_	VBP	_	_	_	_	_
38	not	_	_	RB	_	_	_	_	_
39	indicated	_	_	VBN	_	_	_	_	_
40	;	_	_	:	_	_	_	_	_
41	likewise	_	_	RB	_	_	_	_	_
42	,	_	_	,	_	_	_	_	_
43	excessive	_	_	JJ	_	_	_	_	_
44	therapeutic	_	_	JJ	_	_	_	_	_
45	dosage	_	_	NN	_	_	_	_	_
46	regimens	_	_	NNS	_	_	_	_	_
47	are	_	_	VBP	_	_	_	_	_
48	also	_	_	RB	_	_	_	_	_
49	considered	_	_	VBN	_	_	_	_	_
50	inadequate	_	_	JJ	_	_	_	_	_
51	uses	_	_	NNS	_	_	_	_	_
52	of	_	_	IN	_	_	_	_	_
53	antibiotics	_	_	NNS	_	_	_	_	_
54	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	specific	_	_	JJ	_	_	_	_	_
4	case	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	Spain	_	_	NNP	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	consumption	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	antibiotics	_	_	NNS	_	_	_	_	_
12	for	_	_	IN	_	_	_	_	_
13	outpatients	_	_	NNS	_	_	_	_	_
14	is	_	_	VBZ	_	_	_	_	_
15	above	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	European	_	_	JJ	_	_	_	_	_
18	average	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	hospitals	_	_	NNS	_	_	_	_	_
23	their	_	_	PRP$	_	_	_	_	_
24	prescription	_	_	NN	_	_	_	_	_
25	is	_	_	VBZ	_	_	_	_	_
26	increasing	_	_	VBG	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	inadequate	_	_	JJ	_	_	_	_	_
3	use	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	antibiotics	_	_	NNS	_	_	_	_	_
6	can	_	_	MD	_	_	_	_	_
7	be	_	_	VB	_	_	_	_	_
8	encouraged	_	_	VBN	_	_	_	_	_
9	by	_	_	IN	_	_	_	_	_
10	self-medication	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	by	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	implementation	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	permissive	_	_	JJ	_	_	_	_	_
17	policies	_	_	NNS	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	terms	_	_	NNS	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	regulation	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	use	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	these	_	_	DT	_	_	_	_	_
27	drugs	_	_	NNS	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	by	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	relationship	_	_	NN	_	_	_	_	_
32	between	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	healthcare	_	_	NN	_	_	_	_	_
35	professional	_	_	NN	_	_	_	_	_
36	and	_	_	CC	_	_	_	_	_
37	the	_	_	DT	_	_	_	_	_
38	patient	_	_	NN	_	_	_	_	_
39	or	_	_	CC	_	_	_	_	_
40	by	_	_	IN	_	_	_	_	_
41	the	_	_	DT	_	_	_	_	_
42	knowledge	_	_	NN	_	_	_	_	_
43	and	_	_	CC	_	_	_	_	_
44	attitudes	_	_	NNS	_	_	_	_	_
45	that	_	_	WDT	_	_	_	_	_
46	one	_	_	PRP	_	_	_	_	_
47	has	_	_	VBZ	_	_	_	_	_
48	towards	_	_	IN	_	_	_	_	_
49	them	_	_	PRP	_	_	_	_	_
50	.	_	_	.	_	_	_	_	_


1	Regarding	_	_	VBG	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	latter	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	while	_	_	IN	_	_	_	_	_
6	it	_	_	PRP	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	true	_	_	JJ	_	_	_	_	_
9	that	_	_	IN	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	poor	_	_	JJ	_	_	_	_	_
12	knowledge	_	_	NN	_	_	_	_	_
13	or	_	_	CC	_	_	_	_	_
14	negative	_	_	JJ	_	_	_	_	_
15	attitude	_	_	NN	_	_	_	_	_
16	towards	_	_	IN	_	_	_	_	_
17	antibiotics	_	_	NNS	_	_	_	_	_
18	leads	_	_	VBZ	_	_	_	_	_
19	inevitably	_	_	RB	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	bad	_	_	JJ	_	_	_	_	_
22	clinical	_	_	JJ	_	_	_	_	_
23	practice	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	practical	_	_	JJ	_	_	_	_	_
26	skills	_	_	NNS	_	_	_	_	_
27	are	_	_	VBP	_	_	_	_	_
28	not	_	_	RB	_	_	_	_	_
29	always	_	_	RB	_	_	_	_	_
30	a	_	_	DT	_	_	_	_	_
31	reflection	_	_	NN	_	_	_	_	_
32	of	_	_	IN	_	_	_	_	_
33	knowledge	_	_	NN	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	a	_	_	DT	_	_	_	_	_
36	situation	_	_	NN	_	_	_	_	_
37	known	_	_	VBN	_	_	_	_	_
38	as	_	_	IN	_	_	_	_	_
39	“	_	_	``	_	_	_	_	_
40	theory	_	_	NN	_	_	_	_	_
41	–	_	_	:	_	_	_	_	_
42	practice	_	_	NN	_	_	_	_	_
43	gap	_	_	NN	_	_	_	_	_
44	”	_	_	''	_	_	_	_	_
45	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	date	_	_	VB	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	studies	_	_	NNS	_	_	_	_	_
6	which	_	_	WDT	_	_	_	_	_
7	have	_	_	VBP	_	_	_	_	_
8	evaluated	_	_	VBN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	training	_	_	NN	_	_	_	_	_
11	that	_	_	WDT	_	_	_	_	_
12	healthcare	_	_	NN	_	_	_	_	_
13	students	_	_	NNS	_	_	_	_	_
14	have	_	_	VBP	_	_	_	_	_
15	about	_	_	IN	_	_	_	_	_
16	infectious	_	_	JJ	_	_	_	_	_
17	diseases	_	_	NNS	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	antimicrobial	_	_	JJ	_	_	_	_	_
20	resistance	_	_	NN	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	safe	_	_	JJ	_	_	_	_	_
23	use	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	antibiotics	_	_	NNS	_	_	_	_	_
26	have	_	_	VBP	_	_	_	_	_
27	been	_	_	VBN	_	_	_	_	_
28	mainly	_	_	RB	_	_	_	_	_
29	carried	_	_	VBN	_	_	_	_	_
30	out	_	_	RP	_	_	_	_	_
31	in	_	_	IN	_	_	_	_	_
32	students	_	_	NNS	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	medicine	_	_	NN	_	_	_	_	_
35	and	_	_	CC	_	_	_	_	_
36	pharmacy	_	_	NN	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	besides	_	_	IN	_	_	_	_	_
39	students	_	_	NNS	_	_	_	_	_
40	from	_	_	IN	_	_	_	_	_
41	other	_	_	JJ	_	_	_	_	_
42	disciplines	_	_	NNS	_	_	_	_	_
43	such	_	_	JJ	_	_	_	_	_
44	as	_	_	IN	_	_	_	_	_
45	dentistry	_	_	NN	_	_	_	_	_
46	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	taking	_	_	VBG	_	_	_	_	_
4	into	_	_	IN	_	_	_	_	_
5	account	_	_	NN	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	control	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	antibiotic	_	_	JJ	_	_	_	_	_
11	resistance	_	_	NN	_	_	_	_	_
12	requires	_	_	VBZ	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	multidisciplinary	_	_	JJ	_	_	_	_	_
15	approach	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	that	_	_	IN	_	_	_	_	_
19	nursing	_	_	VBG	_	_	_	_	_
20	staff	_	_	NN	_	_	_	_	_
21	play	_	_	VBP	_	_	_	_	_
22	a	_	_	DT	_	_	_	_	_
23	key	_	_	JJ	_	_	_	_	_
24	role	_	_	NN	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	rational	_	_	JJ	_	_	_	_	_
28	use	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	antibiotics	_	_	NNS	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	as	_	_	IN	_	_	_	_	_
33	teachers	_	_	NNS	_	_	_	_	_
34	of	_	_	IN	_	_	_	_	_
35	patients	_	_	NNS	_	_	_	_	_
36	,	_	_	,	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	as	_	_	IN	_	_	_	_	_
39	future	_	_	JJ	_	_	_	_	_
40	drug	_	_	NN	_	_	_	_	_
41	prescribers	_	_	NNS	_	_	_	_	_
42	in	_	_	IN	_	_	_	_	_
43	our	_	_	PRP$	_	_	_	_	_
44	country	_	_	NN	_	_	_	_	_
45	,	_	_	,	_	_	_	_	_
46	the	_	_	DT	_	_	_	_	_
47	training	_	_	NN	_	_	_	_	_
48	of	_	_	IN	_	_	_	_	_
49	nurses	_	_	NNS	_	_	_	_	_
50	could	_	_	MD	_	_	_	_	_
51	have	_	_	VB	_	_	_	_	_
52	an	_	_	DT	_	_	_	_	_
53	important	_	_	JJ	_	_	_	_	_
54	impact	_	_	NN	_	_	_	_	_
55	in	_	_	IN	_	_	_	_	_
56	reducing	_	_	VBG	_	_	_	_	_
57	the	_	_	DT	_	_	_	_	_
58	incidence	_	_	NN	_	_	_	_	_
59	of	_	_	IN	_	_	_	_	_
60	antibiotic	_	_	JJ	_	_	_	_	_
61	resistance	_	_	NN	_	_	_	_	_
62	.	_	_	.	_	_	_	_	_


1	Thus	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	objective	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	this	_	_	DT	_	_	_	_	_
7	paper	_	_	NN	_	_	_	_	_
8	has	_	_	VBZ	_	_	_	_	_
9	been	_	_	VBN	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	determine	_	_	VB	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	nursing	_	_	VBG	_	_	_	_	_
14	students	_	_	NNS	_	_	_	_	_
15	’	_	_	POS	_	_	_	_	_
16	knowledge	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	awareness	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	antibiotic	_	_	JJ	_	_	_	_	_
21	use	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	resistance	_	_	NN	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	stewardship	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_

